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Neural crest cells (NCCs) are essential components of the sympathetic nervous system, skin, craniofacial skeleton, and aortic arch. It has been
known for many years that perturbation of migration, proliferation, and/or differentiation of these cells leads to birth defects such as cleft palate
and persistent truncus arteriosus (PTA). Previously, we had shown that disruption of the platelet-derived growth factor receptor (PDGFR) α in
NCCs resulted in defects in craniofacial and aortic arch development, the latter with variable penetrance. Because we observed ventricular septal
defects in embryos that are null for the PDGFRβ, we hypothesized that both PDGF receptors are involved in NCC formation. Here, we show that
both receptors are expressed in cardiac NCCs and that the combined loss of the PDGFRα and PDGFRβ in NCCs resulted in NCC-related heart
abnormalities, including PTA and a ventricular septal defect (VSD). Using NCC lineage tracing, we observed that loss of PDGF receptor signaling
resulted in reduced NCCs in the conotruncus region, leading to defects in aortic arch septation. These results indicate that while PDGFRα plays a
predominant role in NCC development, the PDGFRβ is expressed by and functions in cardiac NCCs. Combined PDGF receptor signaling is
required for sufficient recruitment of cardiac NCCs into the conotruncal region and for formation of the aortico-pulmonary and ventricular septum.
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Cardiac NCCs delaminate from the dorsal neural tube
between the midotic placode and the third somite and migrate
ventrally to form a component of the vascular smooth muscle
of the aortic arch as well as the aortico-pulmonary and
ventricular septum. Classic experiments in the chick (Kirby et
al., 1983) and multiple mutations in the mouse (Stoller and
Epstein, 2005) have demonstrated that defects in this cell
population cause heart malformations including persistent
truncus arteriosus (PTA), ventricular septal defects (VSD), and
aortic arch artery abnormalities. It is clear from these results
that cardiac NCCs play an important part in the dynamic
morphogenesis that occurs in the remodeling of the outflow
tract into the asymmetric aortic arch, but their exact mode of
action is not known. As the cardiac NCCs migrate along the⁎ Corresponding author.
E-mail address: michelle.tallquist@utsouthwestern.edu (M.D. Tallquist).
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doi:10.1016/j.ydbio.2007.04.023arch arteries into the conotruncal region of the heart, some
cells differentiate into vascular smooth muscle cells (VSMC)
during this process. Other cells continue to migrate into the
aortic sac where they proliferate and contribute to the aortico-
pulmonary septum. Many cellular signals are involved in
controlling NCC delamination, adhesion, migration, prolifera-
tion, remodeling, and survival, and defects in any of these
signals can result in congenital heart defects (reviewed by
Hutson and Kirby, 2003b; Maschhoff and Baldwin, 2000;
Stoller and Epstein, 2005).
It has been established that disruption of PDGFRα signaling
causes defects in cardiac and cranial NCC populations,
including melanocytes and cells of the palate and aortic arch
(Ding et al., 2004; Klinghoffer et al., 2002; Morrison-Graham et
al., 1992; Soriano, 1997; Tallquist and Soriano, 2003). Previous
analyses of the PDGFRα null and Patch (Ph) mutant allele mice
(a naturally occurring PDGFRα deletion) suggested that cell
survival or matrix deposition is the primary function of
PDGFRα signaling (Morrison-Graham et al., 1992; Soriano,
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was observed in the NCC specific deletion of the PDGFRα
(Tallquist and Soriano, 2003). These findings suggest that the
survival and potentially the matrix defects observed in the
PDGFRα null may have resulted from loss of PDGFRα in non-
neural crest cells.
One difficulty in identifying the cellular cause of the aortic
arch defects in PDGFRα mutants is the incomplete penetrance
of the phenotype. This phenotypic variability may be caused
by genetic modifiers or compensatory signaling in NCCs. A
candidate protein that could compensate for loss of the
PDGFRα is the PDGFRβ. PDGFRβ is expressed in many
mesenchymal cells in the early embryo (Shinbrot et al., 1994).
In addition, both receptors can bind the PDGFBB ligand and
signal through many similar intracellular pathways. Mice
lacking PDGFRβ or PDGFB die perinatally from vascular
defects as a result of insufficient expansion of VSMC and
pericyte formation (Leveen et al., 1994; Soriano, 1994). No
overt craniofacial defects have been identified, although a
dilation of the heart was observed in embryos deficient for the
PDGFB ligand (Bjarnegard et al., 2004; Leveen et al., 1994).
Interestingly, previous analysis of embryos possessing hypo-
morphic alleles of both PDGF receptors demonstrated that
these two receptors can interact genetically (Klinghoffer et al.,
2002).
To investigate this potential interaction we analyzed embryos
with tissue specific deletion of both PDGF receptors in NCCs.
Here, we observed that loss of the PDGFRβ exacerbated the
previously described PDGFRα phenotype in the cardiac NCCs
and resulted in PTA with 100% penetrance. While the initial
delamination, migration, proliferation, and differentiation of
NCCs was normal, the cause of PTAwas the reduced ability of
the PDGF receptor deficient cells to populate the outflow tract.
These results suggest that PDGF receptor signaling instructs
migration of the cardiac NCC population into the conotruncus
region and demonstrate that these receptors are not required for
the differentiation of the cardiac NCCs to form vascular
smooth muscle.
Materials and methods
Mice
The PDGFRα NCC conditional/R26R-LacZ mouse line (PDGFRα fl/fl;
R26R-LacZtg/tg) was described previously (Tallquist and Soriano, 2003).
Mice possessing the PDGFRβ conditional (PDGFRβ fl) and PDGFRα locus
driven nuclear-localized green fluorescent protein (Hamilton et al., 2003)
(PDGFRαGFP) alleles were kindly provided by P. Soriano (Fred Hutchinson
Cancer Research Center). The PDGFRβ conditional animals will be
described elsewhere in detail. Briefly, following Cre-mediated recombination,
exons 1–6 are excised, and a deletion similar to the PDGFRβ null allele is
generated (Soriano, 1994). Wnt1-CreTg mice were kindly provided by A.
McMahon (Harvard University). To generate animals which lacked PDGF
receptors in NCC populations, female mice were maintained as PDGFRα fl/fl;
PDGFRβ fl/fl; R26R-LacZ tg/tg mice and crossed to PDGFRα fl/+; PDGFRβ fl/+;
Wnt1-Cre tg/+ male mice. From these crosses, we cannot generate bona fide wild
type littermate controls, therefore, we use embryos that are heterozygous for the
floxed alleles as controls. The two genotypes used most often as controls were
(PDGFRα fl/+; PDGFRβ fl/+, and PDGFRα fl/+; PDGFRβ fl/+; Wnt1-Cre tg/+).
Embryos bearing these genotypes were similar to wild type embryos.Western blot analysis
Protein was isolated from the first and second branchial arches of control and
NCC conditional E10.5 embryos. Actin and Erk1/2 antibodies were used as
loading controls. The antibodies were obtained from the following sources: Erk
1/2, 06-182 (Upstate Biotechnology); PDGFRα, SSC-20 (Santa Cruz);
cytoskeletal actin (Novus Biologicals); and PDGFRβ, 90A (a kind gift from
A. Kazlauskas, Harvard).
Resin corrosion casting
Resin casting was done using Batson's #17 plastic replica and corrosion kit
(Polysciences; Warrington, PA). The protocol was carried out on E18.5 embryos
as described previously (Tallquist and Soriano, 2003).
Histology and immunohistochemistry
Hematoxylin and eosin staining were performed on paraffin sections
according to standard procedures. PDGFRβ expression was detected on 10 μm
frozen sections using 1:200 dilution of the CD140b antibody (ebioscience).
αSMA expression was detected on paraffin sections with a 1:1000 dilution of
the Clone 1A4 antibody (Sigma). Secondary antibodies were anti-rat and anti-
mouse Alexafluor 594 (Molecular Probes), respectively. For the E10.5
PDGFRαGFP images an anti-GFP antibody (Clontech, JL-8) was used to detect
the GFP protein and anti-mouse Alexafluor 498 (Molecular Probes) was used for
the secondary antibody. For TUNEL staining, the embryos were paraffin
embedded and serial sectioned. TUNEL labeling was carried out as previously
described (Tallquist and Soriano, 2003).
BrdU (Sigma), 100 μg/g of body weight, was injected (i.p) into timed
pregnant females. 2 h later embryos were fixed with 4% paraformaldehyde
overnight. Embryos were paraffin embedded, sectioned and prepared for
immunohistochemsitry. After antigen retrieval, sections were incubated with
anti-BrdU antibody at a 1:50 dilution (Pharmingen) and an anti-mouse
Alexafluor 594 secondary antibody (Molecular Probes) was used as a secondary.
In addition, sections were stained for DAPI. Nine sections from one embryo of
each genotype were quantified at 20X field of view. Outflow tract regions from
E10.5–E12.5 embryos were examined.
NCC lineage tracing
For the NCC lineage tracing we used the Wnt1-CreTg, R26R-LacZ reporter
system has been previously described (Jiang et al., 2000). For whole mount
staining, the ventral thoracic region of the embryo was removed to reveal the
aortic arch. The samples were fixed in 2% formaldehyde/0.2% glutaraldehyde in
PBS at 4 °C for 20 min and incubated in X-gal buffer containing 4% X-gal
overnight at room temperature. The embryos were post-fixed in 10% buffered
formalin for 20 min at room temperature. Residual tissue surrounding the aortic
arch and heart were removed for imaging. For transverse images of the aortic
arch at E12.5 and E13.5, embryos were fixed for 1 h in 4% paraformaldehyde,
equilibrated in 10% sucrose, and embedded in OCT for frozen sectioning. For
X-gal staining, 10 μm sections were washed in PBS+0.05% Tween 20 for
20 min at room temperature and incubated in X-gal and buffer overnight. Frozen
sections were counterstained with nuclear fast red (Fisher).Results
Ventricular septal defects in PDGFRβ null hearts
A direct role for the PDGFRα in cardiac NCCs has been
established, but variability in the phenotype of embryos
lacking PDGFRα signaling in the NCCs has prohibited the
identification of the cellular function that is responsible for
this phenotype. One explanation for the incomplete penetrance
of the phenotype is the possibility that the PDGFRβ can
Table 1
Summary of cardiac NCC phenotypes
Control
(n=8)
PDGFRβ
null
(n=10)
PDGFRα
NCC
conditional
(n=4)
PDGFRβ
NCC
conditional
(n=13)
PDGFRα/β
NCC
conditional
(n=25)
PTA n.d. n.d. 25% n.d. 100%
REO n.d. n.d. 50% n.d. 100%
VSD n.d. 80% 75% n.d. 100%* (22/22)
Thymus# – – (3/3) Hypoplastic (7/7)
Thyroid# – – (3/3) – (7/7)
Data obtained from embryos E14.5–E18.5. Dash indicates organ was
phenotypically normal, n.d.—none detected, PTA—persistent truncus arter-
iosus, REO—retroesophageal origin of the right subclavian artery, and VSD—
ventricular septal defects. Controls were littermates that were heterozygous for
the PDGFRα conditional and all combinations of PDGFRβ conditional and
Wnt1CreTg. *n=22 for VSD because we did not evaluate VSD in the corrosion
resin cast aortic arches. #PDGFRβ NCC conditional and PDGFRα/β NCC
conditional embryos between E14.5 and E16.5.
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this possibility we examined PDGFRβ null embryos for NCC
defects. One of the most common cardiac NCC defects is
failure to form the membranous portion of the ventricular
septum, and this defect was observed in embryos bearing the
PDGFRα Ph/Ph allele (Schatteman et al., 1995). The
frequency of this defect has not been documented for
PDGFRα deficient embryos, and this may be because heart
development is delayed in many of these embryos (Fig. 1B).
Although it has been reported previously that PDGFRβ and
PDGFB null embryos exhibit VSD (Betsholtz et al., 2001; Van
Den Akker et al., 2005), the rate and cause of this defect has
not been discussed. Therefore, we investigated the occurrence
of VSD in PDGFRβ null embryos. We found membranous
VSD in 8 out of 10 PDGFRβ null embryos (Fig. 1C). In the
NCC tissue-specific deletion of the PDGFRα we also
observed VSD as previously reported (Tallquist and Soriano,
2003), and the penetrance of this defect was less than 100%
(Fig. 1D and Table 1). Examination of other neural crest
derivatives in PDGFRβ null embryos, such as aortic arch
VSMC, cranial bones, and the thymic lobes revealed no obvious
abnormalities (data not shown). Nonetheless, the presence of
the VSD prompted us to investigate a potential role for the
PDGFRβ in cardiac NCC development.Fig. 1. Ventricular septal defects are observed in PDGFRβ null and PDGF receptor
mutant embryos at E14.5 and E15.5 as indicated. (A) Control embryo with intact ve
Note that the PDGFRα null heart was developmentally delayed. (D) PDGFRαNCC c
hearts. Asterisk indicates the VSD. Scale bar: 200 μm.PDGFRα and PDGFRβ expression in cardiac NCCs
To gain a better understanding of the extent of PDGF
receptor expression in the cardiac NCC, we examined the
receptors' expression at several stages of cardiac development.
Although expression analysis has been accomplished for eachNCC conditional animals. Histological sections of control and PDGF receptor
ntricular septum. (B) PDGFRα−/−, and (C) PDGFRβ−/− embryos exhibit VSD.
onditional, (E) PDGFRβNCC conditional, and (F) PDGFRα/βNCC conditional
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Urtreger et al., 1992; Shinbrot et al., 1994), no reports exist
for the co-expression of the two receptors in the conotruncal
region. Fig. 2 demonstrates that while both receptors were
expressed in cardiac NCCs, they did not have a completelyFig. 2. PDGFRα and PDGFRβ expression in the cardiac outflow tract. PDGFRα e
PDGFRβwas examined using immunohistochemistry. All three images at each stage
were imaged to illustrate PDGF receptor expression during migration of the cardiac N
and pt, pulmonary trunk. Note that the PDGFRα expression is followed using a nucoverlapping profile. At E10.5 and E11.5 the two PDGF
receptors were expressed in the NCCs migrating through the
branchial arches. The PDGFRβ expression was highest in
regions surrounding the arch arteries, but both receptors were
detected in most NCC populations including the mesenchymexpression was tracked using embryos that possessed a PDGFRαGFP allele and
are the same section. Embryonic stage is indicated at the left. Two E10.5 sections
CC. r4, right fourth arch artery; l6 left sixth arch artery; ct, conotruncus; ao, aorta;
lear localized GFP. Scale bar: 200 μm.
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septum (Fig. 2 and data not shown). The PDGFRα had broader
expression than the PDGFRβ as it was detected in the
sclerotome and dermatome in these sections. By E13.5 the
two receptors were no longer similarly expressed. While the
PDGFRβ was robustly expressed in both NCC and non-NCC-
derived VSMC surrounding the aorta, a more restricted pattern
of expression was observed for the PDGFRα. By E15.5 the
PDGFRα was down-regulated in the aortic VSMC but was still
present in the adventitial fibroblasts. PDGFRβ expression
remained in the VSMC region of the aorta and pulmonary trunk.
This expression data supported a potential role for the PDGFRβ
functioning redundantly with the PDGFRα in cardiac NCCs as
they begin to invade the conotruncal region of the heart.
Phenotypic analysis of PDGFRα/β NCC conditional embryos
Based upon the presence of a VSD in the PDGFRβ null
animals we determined if the PDGFRβ was required for NCC
development by generating mice that possessed a tissue specific
deletion of the PDGFRβ in NCCs using the Cre/loxP
recombination system (see Materials and methods). Mice
possessing the Wnt1-CreTg express the Cre recombinase in
the premigratory NCCs and have been used extensively to
generate tissue specific ablation in NCCs and for lineage tracing
experiments (Danielian et al., 1998; Jiang et al., 2000).
PDGFRβfl/fl; Wnt1-CreTg animals were viable and exhibited
no VSD (Fig. 1E) or any other overt NCC defect (data not
shown). These data indicated that either the VSD in the
PDGFRβ null embryos was not cell autonomous to NCCs or
that the deletion of the PDGFRβ in the NCC population was
incomplete in our conditional animals. Western blot analysis
and immunohistochemistry on tissue from conditional mutantsFig. 3. Efficient deletion of the loxP flanked alleles in the PDGFRα/β NCC conditi
branchial arches in (lane 1, PDGFRα fl/fl; PDGFRβ fl/fl); (lane 2, PDGFRα fl/+; PDG
PDGFRα fl/fl;PDGFRβ fl/fl); (lane 5, PDGFRα fl/+; PDGFRβ fl/+; Wnt1CreTg); and (lan
used as a loading control. (B, C) PDGFRβ immunohistochemistry on frozen sec
demonstrating deletion of the PDGFRβ in NCCs. Arrowheads indicate loss of PDGconfirmed that the PDGFRβ expression was greatly reduced in
the branchial arches and the aortic arch in the presence of the
Wnt1-CreTg (Fig. 3). The deletion in the branchial arches
demonstrated not only that the tissue specific deletion of the
PDGFRβ occurred, but also that the PDGFRβ was expressed
abundantly in the NCC component of the first and second
branchial arches (Fig. 3B). NCC deletion of the PDGFRβ
resulted in loss of PDGFRβ from the NCC-derived VSMC but
retention of the receptor in the splanchnic mesoderm-derived
VSMC population surrounding the aorta and pulmonary trunk
(Fig. 3C).
Crosses of hypomorphic alleles of the two PDGF receptors
suggested that there were genetic interactions of the two
receptors in the formation of the cranial NCCs (MT and AR,
unpublished observation, 2005), therefore, we hypothesized
that the presence of the PDGFRα could compensate for the loss
of PDGFRβ in some NCC populations. To test this hypothesis
we generated mice doubly homozygous for PDGF receptor
conditional alleles and also expressing the Wnt1-CreTg
(PDGFR α/β NCC conditional). The efficient deletion of the
PDGFRα in NCC was determined by western blotting (Fig. 3A)
and has also been demonstrated previously (Tallquist and
Soriano, 2003). PDGFRα/β NCC conditional embryos were
recovered at the expected Mendelian ratios throughout
embryogenesis, but 100% of these embryos died at birth. At
birth these animals appeared cyanotic, exhibited a cleft palate
similar to that observed in the PDGFRα NCC conditional
embryos (Tallquist and Soriano, 2003), and likely died due to
cardiovascular abnormalities and the inability to breathe.
Further analysis revealed that loss of the PDGFRβ caused
significantly more severe craniofacial (to be described else-
where) and cardiac NCC phenotypes than what had been re-
ported in the PDGFRα NCC conditional.onal embryos. (A) Western blot analysis of PDGF receptor expression in E10.5
FRβ fl/+; Wnt1CreTg); (lane 3, PDGFRα fl/fl; PDGFRβ fl/+; Wnt1CreTg); (lane 4,
e 6, PDGFRα fl/+; PDGFRβ fl/fl; Wnt1CreTg). Detection of actin and erk1/2 was
tions of (B) E10.5 second branchial arches and (C) E14.5 aortic arch region
FRβ from the VSMC of the aorta. Scale bar: 200 μm.
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defects
Defective thyroid and thymus formation have been
associated with aberrant NCC development (Hutson and
Kirby, 2003a), and recently it has been shown that
PDGFRα-expressing, NCC-derived mesenchyme provides
important signals for thymus expansion in the embryo
(Jenkinson et al., 2007). In the mouse, NCCs begin to populate
the stroma, lobe septae, and the capsule of the thymus at E11.5
(Jiang et al., 2000; Yamazaki et al., 2005). Therefore, we
examined serial histological sections of the neck and upper
thoracic region for thymus and thyroid development. Normal
development of both thyroid and thymus were detected in
PDGFRβ NCC conditional embryos (Table 1), and when we
examined PDGFRα/β NCC conditional embryos, we found
that the thyroid gland was present and normal in size. In
contrast, the development of the thymus was disrupted in the
PDGFRα/β NCC conditional embryos. In 7/7 embryos the
thymus was either absent or hypoplastic and in the neck region
of the embryos. Four out of seven of these thymuses were
located unilaterally (Table 1). These data suggest that either
PDGF receptor signaling was required for proper thymusFig. 4. Aortic arch defects in PDGFRα/βNCC conditional embryos. (A, B) Resin cor
Wnt1-CreTg) embryos exhibited an aortic arch architecture indistinguishable from th
PDGFRβfl/fl;Wnt1-CreTg) embryos possessed persistent truncus arteriosus (asterisk) a
rcc originated from the ascending truncus. (C, D) Transverse histological sections t
embryo. Ao, aorta; dAo, descending aorta; eo, esophagus; lcc, left common carotid a
artery; rsa, right subclavian artery; and tr, trachea. Scale bar: 200 μm.development or was required for migration of NCCs to the
thymic primordia.
To further investigate the development of the cardiac NCC
we examined PDGF receptor NCC conditional animals by resin
corrosion casting and histology, and we found defects in cardiac
NCC derivatives including VSD (Fig. 1F), retroesophageal
origin of the right subclavian artery (REO), and PTA (Fig. 4) in
the mutant embryos. PTA is caused by a failure of NCCs to
either migrate into or remodel the vascular arteries. The end
result of this failure is that the aorta and pulmonary trunk fail to
separate and remain as the primitive truncus arteriosus. The
aberrant origin of the right subclavian is caused by abnormal
regression of the right fourth arch artery. We observed PTA and
REO in every PDGFRα/β NCC conditional embryo that we
examined (25/25; Table 1) compared to the 25% and 50%,
occurrence, respectively, that we observed in the PDGFRα
NCC conditional. These phenotypes were consistent with a
defect in NCCs that contributed to the cardiac outflow tract. The
exacerbated phenotypes provided strong evidence that the
PDGFRβ functions cooperatively with the PDGFRα during
cardiac NCC development.
The PDGFRβ has a well-established role in the proliferation
of VSMC (Betsholtz et al., 2001), and recent evidence suggestsrosion casts of E18.5 aortic arch vessels. (A) Control (PDGFRαfl/+;PDGFRβ fl/+;
at of wild type embryos while (B) PDGFRα/β NCC conditional (PDGFRαfl/fl;
nd retroesophageal origin of the right subclavian artery (arrowhead). Note: The
hrough E14.5 aortic arch regions demonstrated the same defects in the mutant
rtery; lsa, left subclavian artery; pt, pulmonary trunk; rcc, right common carotid
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required for the morphogenesis of the symmetric arch arteries
into the mature aortic arch (Kaartinen et al., 2004; Li et al.,
2005; Oh et al., 2005). Therefore, we examined the VSMC
component of the aortic arch in the PDGF receptor NCC
conditional embryos at E11.5 to determine if failure in terminal
differentiation of NCCs might be the cause of the aortic arch
defects. The presence of α smooth muscle actin (αSMA)-
positive cells around the aortic arch arteries demonstrated that
NCCs were present and capable of differentiating into VSMC in
the absence of PDGF receptor expression (Fig. 5). At E12.5 and
13.5 we also observed a normal pattern of smooth muscle cells
surrounding the pharyngeal arch arteries (data not shown).
These data demonstrated that PDGF receptor expression was
not required for differentiation of NCCs into VSMC of the
aortic arch and that the aortic arch defects observed could not be
explained by absence of this cell lineage.
NCC migration defects occur in the conotruncus region of the
aortic arch
We next analyzed the candidate cellular responses controlled
by PDGF receptor signal transduction using common embry-
ological techniques for proliferation, apoptosis, and migration.
Defects in proliferation, migration, and apoptosis did not
contribute to the observed phenotypes of the PDGFRα NCCFig. 5. Normal smooth muscle cell distribution in PDGFRα/β NCC conditional embry
conditional embryos were stained for expression of α smooth muscle actin (αSMA)conditional animals (Tallquist and Soriano, 2003). However,
because PDGFRβ signaling in NCCs may have masked
disruptions in these processes, we reexamined these potential
cellular defects in our double NCC conditional embryos.
Proliferation in the aortic sac was analyzed using BrdU
incorporation of proliferating cells. Fate mapping of the cardiac
neural crest in the mouse has shown that cells begin to migrate
as two symmetrical prongs to the conotruncus region around
E10.0, and septation of the aortico-pulmonary region begins
around E12.0 (Jiang et al., 2000). Therefore, we analyzed
proliferation of cells within the conotruncal region of embryos
between the stages of E10.5 and E11.5 to assess the
proliferation rate of NCCs in our PDGFRα/β NCC conditional
embryos. The proliferation index of cells in outflow tract
region of PDGFRα/β NCC conditional embryos demonstrated
that there was no significant change in the number of
proliferating cells compared to littermate controls (E10.5:
control 33±3%, mutant 36±7%; E11.5: control 26±4%,
mutant 23±2%). Fig. 6 demonstrates that a similar rate of
proliferation was observed in the outflow tract cushion of
mutant and control embryos at E10.5. Finally, we also examined
NCC populations for apoptosis in the conotruncal region at
E10.5–E12.5, and PDGFRα/β NCC conditional mutants
contained no increase in TUNEL positive cells in the cono-
truncal region compared to litter mate controls (data not
shown). Taken together, these data demonstrated that prolife-o arch arteries. Transverse sections through E11.5 control and PDGFRα/βNCC
Scale bar: 200 μm.
Fig. 6. NCC proliferation remains unchanged in the outflow tract of PDGFRα/β NCC conditional mutants. Transverse sections of E10.5 aortic sac stained for BrdU
incorporation. (A–C) Control (PDGFRαfl/+; PDGFRβfl/+;Wnt1-CreTg) and (D–F) PDGFRα/β NCC conditional (PDGFRαfl/fl; PDGFRβfl/fl;Wnt1-CreTg) embryos.
(A, D) Brightfield images. Boxed region indicates close-up area for fluorescence detection. (B, E) BrdU positive nuclei and (C, F) DAPI stained nuclei. Scale bar:
200 μm.
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PDGFRα and PDGFRβ.
Because neither proliferation nor apoptosis were defective in
the PDGFRα/β NCC conditional embryonic hearts, and the
NCC defects that we observed were concentrated in the
proximal outflow tract we examined NCC migration. NCCs
were traced using mice that possess the R26R-LacZ and Wnt1-
CreTg (Jiang et al., 2000). In these embryos, β-galactosidase is
expressed in migrating NCCs and their descendents. Whole
mount images of E16.5 hearts that possessed NCCs tagged by
β-galactosidase expression revealed a decrease in the apparent
number of NCCs in the aortic arch in PDGFRα/β NCC
conditional compared to control and PDGFRαNCC conditional
hearts (Figs. 7A–C). To determine when the cellular reduction
in NCCs occurred, we examined embryos at earlier stages of
development. At E10.5 and E11.5 we observed normal
migration of cells from the neural tube (Figs. 7D–G). At
E10.5 two streams of NCCs were present in both the control and
PDGFRα/β NCC conditional outflow tracts, but in PDGFRα/β
NCC conditionals the NCCs had not migrated as far into the
outflow tract as the control NCCs. At E11.5 NCCs had entered
the aortic sac but were less abundant in PDGFRα/β NCC
conditional embryos (Figs. 7F–G and F′–G′). By E12.5 and
E13.5 PDGFRα/β NCC conditional embryos possessed far
fewer NCCs in the regions of the aortico-pulmonary septum
when compared to littermate controls (Figs. 7H–K). Figs. 7H′–
K′′ demonstrate the location and numbers of the NCCs at the
levels of the aortico-pulmonary septum and aortic valve leaflets.
The controls had abundant numbers of NCCs surrounding both
the aorta and the pulmonary trunk, while the PDGFRα/β NCC
conditional embryos contained considerably fewer cells. To
determine if the cause of thymic abnormalities was failure of
NCCs from the third branchial pouch to invest in the thymic
primordium, we examined E13.5 control and PDGFRα/β NCCconditional embryos for β-galactosidase expression. We found
that in the control β-galactosidase expressing cells surrounded
the thymic epithelium, but no β-galactosidase expressing cells
were observed in the PDGFRα/β NCC conditional embryo
(data not shown). This suggested that NCCs also failed to
migrate to the thymic epithelium resulting in aberrant thymus
development. Interestingly, cranial, thoracic, and enteric NCC
migration was unperturbed in PDGFRα/β NCC conditional
embryos (data not shown). We infer from this data that PDGF
receptors are important for cardiac NCC migration into the
outflow tract and that the reduction in NCCs reaching the
outflow tract resulted in PTA and VSD.
Discussion
Our study has revealed that PDGF receptor signaling directs
NCC function specifically in the conotruncal region of the aortic
arch. Previous analyses of the PDGFRβ have demonstrated a
role for this receptor in mesoderm-derived VSMC and
pericytes, but nothing was known about the requirement for
PDGFRβ signal transduction in NCCs. These experiments
demonstrate that the PDGFRβ provides signals to NCCs and
that loss of both receptors causes a severe aortic arch phenotype,
PTA. Our results suggest that NCCs respond to signals of either
of the PDGF receptors. Therefore, presence of one receptor can
partially compensate for loss of the other receptor family
member.
Requirement for the PDGFRβ in cardiac NCCs
Tissue specific ablation in NCCs of the PDGFRβ alone did
not cause any overt NCC phenotypes. This may be because the
Wnt1Cre transgene did not delete the PDGFRβ gene efficiently
or early promptly, resulting in expression of the PDGFRβ that
Fig. 7. Reduced NCC migration into the conotruncus. Detection of NCCs via the R26R-LacZ/Wnt1-CreTg lineage marker. Whole mount β-galactosidase activity of
aortic arches at (A–C) E16.5, (D, E) E10.5, (F, G) E11.5, (H, I) E12.5, (J, K) E13.5. Asterisk indicates aberrant Wnt1-Cre activity that has been previously reported
(Stottmann et al., 2004). Arrows point to furthest migration point of β-galacotosidase-tagged NCC. (D′–K′ and H′′–K′′) figures were transverse sections from control
and mutant embryos. E10.5 and E11.5 sections were generated from the whole mount stained embryos. E12.5 and E13.5 were independent embryos that were frozen
embedded, sectioned, and stained for β-galactosidase activity at the level of the outflow tract. Single prime (′) images were anterior to the double prime (ʺ) images. A
marked reduction in NCCs in the aortico-pulmonary septum of the aortic arch can be observed in the PDGFRα/β NCC conditional embryos at E12.5. Arrowhead
indicates NCCs surrounding the esophagus. Genotypes are as indicated. For whole mount images surrounding tissues were removed from the embryos to enhance
visualization of the aortic arch region. BA2; second branchial arch; es, esophagus; Ao, aorta; dAo, descending aorta; and tr, trachea.
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loss of the PDGFRβ in combination with the PDGFRα in
NCCs lead to a phenotype more severe than the loss of the
PDGFRα alone. In the absence of receptor activation, reduced
numbers of NCCs migrated to the outflow tract. Loss of bothreceptors in NCCs resulted in PTA with 100% penetrance.
These results provide genetic evidence that either of the PDGF
receptors can direct NCC activities and that signaling down-
stream of these receptors is important for the formation of the
NCC-derived components of the aortic arch. Despite the known
794 A.M. Richarte et al. / Developmental Biology 306 (2007) 785–796requirement for PDGFRβ in many VSMC populations, we did
not observe any defects in the PDGF receptor deficient NCCs'
ability to differentiate into αSMA-expressing cells. These data
demonstrate that NCCs do not require PDGF receptor activity
for formation nor proliferation of arch artery smooth muscle.
Potentially, other signaling molecules are required in this
particular cell population.
Our findings are somewhat surprising because the PDGFRα
has such a dominant cranial NCC phenotype, and no definitive
defects have been reported in the NCC derivatives in the
PDGFRβ null embryos. It is likely that the apparent dominance
of the PDGFRα is due to the profile of PDGF ligands that are
expressed in the tissues surrounding the cranial and cardiac
NCC populations. The PDGFRα can be activated by all PDGF
ligands except for PDGFDD (Fredriksson et al., 2004). In
contrast, the PDGFRβ can only bind PDGFBB and PDGFDD.
The PDGFRα/β heterodimer can be activated by either
PDGFBB or PDGFAB dimers. Based on the phenotypes of
the PDGFRα and PDGFRβ NCC conditional embryos, our
analysis suggests that both PDGFA and PDGFB may be the
important ligands for signaling to NCC. The expression profile
of the relevant ligands at the time of NCC migration into the
outflow tract is dynamic. PDGFA expression in the mouse has
been localized to epithelial tissues adjacent to PDGFRα-
expressing mesenchyme (Orr-Urtreger and Lonai, 1992;
Schattemann et al., 1996). No expression has been reported in
the outflow tract, although PDGFA expression has been noted
in the endocardial cushions in the avian system (Van Den Akker
et al., 2005). PDGFB, which binds homo and heterodimers of
the receptors, is expressed in all endothelial cells of the
developing embryo (Hellstrom et al., 1999; Lindahl et al., 1997)
and has been reported in the avian ventricular septum (Van Den
Akker et al., 2005). During embryogenesis PDGFD is found in
the myocardium at E12.5, and at E13.5 PDGFD is expressed by
developing arterial VSMC (Ponten et al., 2005). While PDGFC
expression has been shown to play a role in cranial NCC
development (Ding et al., 2004), PDGFC mRNA is not
expressed in the heart nor the vascular endothelium (Aase et
al., 2002; Ding et al., 2000). Taken together, these data indicate
that PDGFA and PDGFB may play a predominant role in the
NCC migration and function in the developing outflow tract. In
support of this idea, simultaneous deletion of PDGFA and
PDGFC resulted in an atrial septal defect, but no aorticopul-
monary nor ventricular septal defect was reported (Ding et al.,
2000).
PDGF receptor-driven migration
Migration is one of the characteristic features of NCCs and
failure of this cell population to reach its destination results in a
variety of craniofacial and cardiac defects (Kirby et al., 1983;
Phillips et al., 1987; Waldo et al., 1999). Although many
receptors and matrix molecules have been implicated in NCC
guidance and migration, little is known about how these signals
direct aortic arch morphogenesis. Disruption of neuropilin1,
plexin A2, or semaphorin 3C leads to a similar reduction in
NCCs in the proximal outflow tract (Brown et al., 2001; Feineret al., 2001; Kawasaki et al., 1999), but PTA occurs with a
decreased frequency compared to the PDGFRα/β NCC
conditional embryos. Some members of the TGFβ super family
have also been implicated in NCC formation of the outflow
tract. NCC specific ablation of BMPRIA (Stottmann et al.,
2004), TGFβRII (Wurdak et al., 2005), ALK5 (Wang et al.,
2006) or ALK2 (Kaartinen et al., 2004) results in defects of the
aortic arch, but only the ALK2 mutation leads to defective NCC
migration. Similar to what we observe in our PDGFRα/β NCC
conditional embryos, ALK2 NCC conditional animals initiate
migration but fail to migrate to the proximal zone of the outflow
tract. It is of interest that both the ALK2 and PDGF receptor
NCC conditional embryos exhibit PTA with 100% penetrance.
Because these two receptors transduce signals through different
intracellular components, it will be important to discover how
the signaling pathways downstream of each receptor direct
NCC migration.
Although one of the predominant actions of the PDGFRα
and PDGFRβ in vitro is migration, and migration has been
suggested as one of the mechanisms for guiding pericytes to
endothelial cells, only two other examples of PDGF-directed
migration have been demonstrated in vivo. In Drosophila, the
PDGF receptor homolog, PVR, directs border cell migration to
the oocyte (Duchek et al., 2001). In this system the target cell,
the oocyte, expresses the PVF1 ligand, and the receptor-
expressing cells are guided to the target. In Xenopus, PDGFAA
expression directs the migration of PDGFRα-expressing
mesodermal cells towards the animal pole (Nagel et al.,
2004). A similar situation could be occurring in the region of
the conotruncus.
Our NCC cell tracing indicated that PDGF signal transduc-
tion resulted in reduced NCCs in the proximal outflow tract, but
our data does not rule out the possibility that PDGF stimulation
could also affect outflow tract remodeling. The migration of
NCCs is dependent on numerous extracellular matrix (ECM)
proteins, and it may be that loss of receptor signaling causes a
change in expression of various ECM proteins or matrix
metalloproteases (Maschhoff and Baldwin, 2000). These
disruptions could result in loss of cell adhesion or an increase
of ECM, respectively. Therefore, PDGF receptors could
additionally affect NCC migration by altering gene expression
or metalloprotease activities. In support of this additional
possibility, there is evidence that MMP-2 expression is lost in
NCCs in Ph/Ph mutant mice. Recently, loss of PINCH1 or N-
cadherin in NCC has been demonstrated to lead to a failure in
aorticopulmonary septation that may result from inadequate
adhesion or ECM in the outflow tract region. Further studies on
the NCC conditional and signaling point mutants of the PDGF
receptors (Heuchel et al., 1999; Klinghoffer et al., 2002) will
allow us to determine the signaling pathways involved in
directing cardiac NCC migration in vivo.
The combined function of PDGF receptor signal transduction
in vivo
Understanding the combined functions of the PDGF
receptors during embryogenesis and organogenesis is a
795A.M. Richarte et al. / Developmental Biology 306 (2007) 785–796complicated endeavor. Because homozygous nulls of each
receptor results in embryonic lethality (Soriano, 1994; Soriano,
1997), the expected frequency of double homozygous null
embryos is only 1 out of 16 by double heterozygous crosses.
These analyses are further complicated by the fact that a high
percentage of PDGFRα null embryos die before E10.5 likely
due to defects in spongiotrophoblasts cells (Hamilton et al.,
2003). A hint that the receptors can cooperate during
embryogenesis was revealed when mice carrying hypomorphic
alleles of both receptors were generated (Klinghoffer et al.,
2002). When either PDGF receptor is mutated such that it can
no longer signal through the PI3K pathway, early embryonic
lethality is circumvented, but when embryos are homozygous
for both mutant receptors embryos die between E10.5 and E13.5
and exhibit a phenotype similar to the PDGFRα null embryos
(Klinghoffer et al., 2002). These data suggested that the
PDGFRβ is expressed in several of the same cell populations
as the PDGFRα and can partially compensate for PDGFRα
signal transduction when PDGFRα signaling is impaired. Our
results are in agreement with these studies and specifically
demonstrate that the two receptors are required in the cardiac
NCC population. Our data illustrates the utility of conditional
analysis and suggests that these two receptors have both
overlapping and unique cellular roles. In NCCs, the PDGFRβ
appears to play a minor role in the formation of the cranial bones
but plays an essential role in migration of the cardiac neural
crest.
In this study we have demonstrated that loss of both PDGF
receptors consistently leads to PTA and VSD. Because the two
PDGF receptors are on different chromosomes it is unlikely that
simultaneous recessive mutations in these genes are responsible
for NCC-related diseases, but disruption of molecules down-
stream of both receptors may lead to phenotypes similar to
those that we observe. A thorough analysis of the signal
transduction and gene induction downstream of the receptors
will provide essential information regarding some of the
candidate molecules that may lead to these common birth
defects.
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